These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 4675007)

  • 1. Determinants of prothrombinase activity and modification of prothrombin conversion by thrombin-treated factor V.
    Kandall C; Akinbami TK; Colman RW
    Br J Haematol; 1972 Dec; 23(6):655-68. PubMed ID: 4675007
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of blood clotting factor V in the conversion of prothrombin and a decarboxy prothrombin into thrombin.
    Vermeer C; Govers-Riemslag JW; Soute BA; Lindhout MJ; Kop J; Hemker HC
    Biochim Biophys Acta; 1978 Feb; 538(3):521-33. PubMed ID: 564211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between factor V and activated factor X in the generation of prothrombinase.
    Barton PG; Jackson CM; Hanahan DJ
    Nature; 1967 May; 214(5091):923-4. PubMed ID: 6054988
    [No Abstract]   [Full Text] [Related]  

  • 4. Basic aspects of blood clotting: thrombokinase and cofactors in the conversion of prothrombin to thrombin.
    Ferguson JH; Ennis EG; Latridis PG; White NB
    Thromb Diath Haemorrh; 1967 Dec; 18(3-4):647-63. PubMed ID: 5590251
    [No Abstract]   [Full Text] [Related]  

  • 5. Activation of prothrombin as measured by the conversion of Nalpha-benzoylarginine ethyl ester.
    Ong TC; Loh KW
    Biol Chem Hoppe Seyler; 1986 May; 367(5):395-400. PubMed ID: 3741619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium and prothrombin activation.
    Mann KG; Fass DN
    Mayo Clin Proc; 1974 Dec; 49(12):929-32. PubMed ID: 4613965
    [No Abstract]   [Full Text] [Related]  

  • 7. THROMBOPLASTIN FORMATION.
    POOL JG
    Annu Rev Med; 1964; 15():215-32. PubMed ID: 14133846
    [No Abstract]   [Full Text] [Related]  

  • 8. Tumor cell generation of thrombin via functional prothrombinase assembly.
    VanDeWater L; Tracy PB; Aronson D; Mann KG; Dvorak HF
    Cancer Res; 1985 Nov; 45(11 Pt 1):5521-5. PubMed ID: 4053025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood coagulation.
    Jackson CM; Nemerson Y
    Annu Rev Biochem; 1980; 49():765-811. PubMed ID: 6996572
    [No Abstract]   [Full Text] [Related]  

  • 10. Removal from bovine prothrombin of the substrate for Russell's viper venom.
    Milstone JH; Oulianoff N
    Thromb Diath Haemorrh; 1969 Apr; 21(2):203-16. PubMed ID: 5814014
    [No Abstract]   [Full Text] [Related]  

  • 11. OBSERVATIONS ON THE INTERACTION OF PHOSPHOLIPIDS AND CERTAIN CLOTTING FACTORS IN PROTHROMBIN ACTIVATOR FORMATION.
    PAPAHADJOPOULOS D; HANAHAN DJ
    Biochim Biophys Acta; 1964 Aug; 90():436-9. PubMed ID: 14220741
    [No Abstract]   [Full Text] [Related]  

  • 12. Activation of bovine prothrombin as monitored by the clotting assay.
    Ong TC; Sothy SP
    Biol Chem Hoppe Seyler; 1990 Jan; 371(1):63-8. PubMed ID: 2322420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factor-V activation by thrombin and its role in prothrombin conversion.
    Giddings JC; Bloom AL
    Br J Haematol; 1975 Feb; 29(2):349-64. PubMed ID: 1191555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional and stric characteristics of modified thrombin zymogen.
    Marciniak E
    Thromb Diath Haemorrh; 1970 Dec; 24(3):361-72. PubMed ID: 5503937
    [No Abstract]   [Full Text] [Related]  

  • 15. Heparin and low molecular weight heparins inhibit prothrombinase formation but not its activity in plasma.
    Ofosu FA; Lormeau JC; Craven S; Dewar L; Anvari N
    Thromb Haemost; 1994 Dec; 72(6):862-8. PubMed ID: 7740455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of the prothrombin fragment 2 domain to the function of factor Va in the prothrombinase complex.
    Krishnaswamy S; Walker RK
    Biochemistry; 1997 Mar; 36(11):3319-30. PubMed ID: 9116010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Coagulation tests from capillary blood. Determination of thromboplastin time, thrombin time, fibrinogen, factor II (prothrombin), factor V (accelerin) and factor X (Stuart-Prower factor) from capillary blood].
    Muntean W
    Z Kinderheilkd; 1975; 118(4):337-46. PubMed ID: 1130122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure and function of factor X: properties, activation, and activity in prothrombinase. A retrospective in a historical context.
    Jackson CM
    J Thromb Thrombolysis; 2021 Aug; 52(2):371-378. PubMed ID: 33725285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of inhibition of platelet coagulant activity.
    Ellis V; Scully MF; Kakkar VV
    Adv Exp Med Biol; 1985; 192():373-87. PubMed ID: 2422887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of the conversion mechanism of prothrombin into thrombin.
    Okabe H
    Tohoku J Exp Med; 1974 Nov; 114(3):215-25. PubMed ID: 4456684
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.